Farahani P, Khan S, Oatway M, Dziarmaga A. EXPLORING THE DISTRIBUTION OF PRESCRIPTION FOR SULFONYLUREAS IN PATIENTS WITH TYPE 2 DIABETES ACCORDING TO CARDIOVASCULAR RISK FACTORS WITHIN A CANADIAN PRIMARY CARE SETTING. J Popl Ther Clin Pharmacol. 2018;22(3). Accessed November 19, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/249